Clinical Trial Update: Behavioral and Subjective Efficacy of Ramelteon in Subjects With a History of Polydrug Abuse [Phase 2]

View source ↗

Summary

Phase 2 evaluation of ramelteon in individuals with a history of polydrug abuse has completed, reporting behavioral and subjective efficacy outcomes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Drug Abuse

Drugs mentioned

• Ramelteon (ramelteon)

Snippet

Sponsor: Takeda | Conditions: Drug Abuse | Phase 2 | Status: COMPLETED